Calviri Calviri is a company that develops diagnostic and therapeutic products, as well as vaccines aimed to prevent cancer. | |||
Founding Date | Founding Date 2003 | Founding Date 2018 | Founding Date 1997 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations Oslo, NO HQ | Locations Phoenix, US HQ | Locations Lund, SE HQ |
Employees | Employees 215% increase | Employees 16 | Employees 118 |
Valuation ($) | Valuation ($) 31.4 m | Valuation ($) N/A | Valuation ($) 285.9 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) kr226.5m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit kr226.6m (FY, 2025) |
Net income | Net income (kr60m) (FY, 2025) | Net income N/A | Net income (kr332.9m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 10.4m | Total funding raised $ 2.3m | Total funding raised N/A |
Calviri is a company that develops diagnostic and therapeutic products, as well as vaccines aimed to prevent cancer.
View company
BioInvent focuses on the discovery and development of antibody-based drugs against cancer.
View company